IDO1 and neoplasm: Through integrating multi-omics analyses, we speculated that abnormal IDO1 upregulation of tumor cells involved in anomalous tryptophan metabolism could release L-kyn enriched EVs, which may partly lead to a high level of L-kyn in EVs derived from tumor tissues and plasma from OC patients, as validated in another clinical cohort.